Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock news
- Cytophage Technologies (CYTO:CA) on Tuesday said its chief operating officer, Heather Medwick, left the company effective March 31 following a corporate restructuring.
- The company said the restructuring is aimed at streamlining operations, reducing costs and preserving financial resources.
- Cytophage added that a special committee continues to evaluate strategic alternatives, including a potential financing, with no timeline set for a decision.